Sunshine Biopharma (SBFM) Exchange Rate Effect (2015 - 2026)
Sunshine Biopharma (SBFM) posted Exchange Rate Effect of -$33677.0 for Q1 2026, down 104.44% on a QoQ basis from $758585.0 in Q4 2025, and down 230.26% year-over-year from $25852.9 in Q1 2025.
Sunshine Biopharma (SBFM) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Sunshine Biopharma's Exchange Rate Effect history runs 12 years deep, the most recent figure standing at -$33677.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 230.26% year-over-year to -$33677.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $832270.0 (up 169.66% YoY) and the FY2025 annual result came in at $855750.0, up 182.02% from the prior year.
- Exchange Rate Effect was -$33677.0 for Q1 2026 at Sunshine Biopharma, down from $758585.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $772282.0 in Q3 2024 and bottomed at -$1.3 million in Q2 2024.
- A 5-year average of $18350.5 and a median of -$1007.0 in 2022 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 5577.46% in 2024, while the deepest fall reached 418.6% in 2024.
- Sunshine Biopharma's Exchange Rate Effect stood at $104542.0 in 2022, then jumped by 376.66% to $498306.0 in 2023, then tumbled by 227.49% to -$635298.0 in 2024, then soared by 219.41% to $758585.0 in 2025, then sank by 104.44% to -$33677.0 in 2026.
- Business Quant data shows SBFM's Exchange Rate Effect at -$33677.0 in Q1 2026, $758585.0 in Q4 2025, and -$228322.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | -33,677.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,677.00 |
| Mar 31, 2026 | -33,677.00 |
| Dec 31, 2025 | 758,585.00 |
| Dec 31, 2025 | 758,585.00 |
| Sep 30, 2025 | -228,322.00 |
| Sep 30, 2025 | -228,322.00 |
| Jun 30, 2025 | 335,684.00 |
| Jun 30, 2025 | 335,684.00 |
| Mar 31, 2025 | -10,197.00 |
| Mar 31, 2025 | -10,197.00 |
| Dec 31, 2024 | -635,298.00 |
| Dec 31, 2024 | -635,298.00 |
| Sep 30, 2024 | 772,282.00 |
| Sep 30, 2024 | 772,282.00 |
| Jun 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | -1.32 Mn |
| Mar 31, 2024 | 141,312.00 |
| Mar 31, 2024 | 141,312.00 |
| Dec 31, 2023 | 498,306.00 |
| Dec 31, 2023 | 498,306.00 |